A new review was published in Volume 16 of Oncotarget on June 25, 2025, titled "Challenges and resistance mechanisms to EGFR targeted therapies in head and neck cancers and breast cancer: Insights ...
Lung cancer in never-smokers exhibits distinct biological characteristics, often leading to late-stage diagnoses due to lack of screening. Targeted therapies, guided by molecular testing, offer ...
An expert discusses how long-term safety considerations are evaluated through clinical trial data and postmarketing surveillance, emphasizing the importance of reporting unexpected adverse events to ...
Key market opportunities in thyroid cancer therapeutics include China's anticipated rise in cases through 2029, the growing importance of targeted therapies and emerging immunotherapies, a robust ...
Breast cancer pathogenesis is influenced by various molecular and environmental risk factors. It begins through the mutation of oncogenes, tumor suppressor genes, and dysregulation of key cell ...
HER2-positive breast cancer is driven by HER2 protein overexpression, historically linked to poor outcomes but now improved by targeted therapies. Treatment varies by stage, involving surgery, ...
Colon, lung, and liver cancers are among the most prevalent and lethal cancers globally. Despite advancements in treatment, these cancers continue to pose significant challenges due to high mortality ...
Identifying BRCAness in tumors, even in the absence of BRCA mutations, broadens the reach of targeted therapies, supporting more individualized and effective cancer treatment approaches. BRCAness ...
Selecting the right targeted therapy or clinical trial for each cancer patient is one of modern oncology’s greatest challenges. Each tumor carries a unique combination of four to five actionable ...
The rapid evolution of advanced therapies like cell and gene therapies is reshaping the oncology landscape and challenging ...
Every cancer diagnosis begins a deeply personal journey, one shaped by both the disease itself and the individual. Cancer ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results